TOP STORIES

• BUSINESS Astellas to Cut 500 More Jobs in Buyout Targeting Commercial Unit
  August 2, 2023

• REGULATORY Generics Panel Initiates Debate toward Proposing Stable Supply Measures, Interim Report Slated for October
  August 1, 2023

• REGULATORY Japan Panel Shelves Decision on Shionogi’s COVID Vaccine over Efficacy Data
  August 1, 2023

• ORGANIZATION IRA Could Create New Type of Drug Loss, Affecting Japan Too: PhRMA Official
  July 31, 2023

• REGULATORY Japan to Buy 20 Million Doses of Pfizer COVID Jab, 5 Million from Moderna
  July 28, 2023

• REGULATORY Japan Likely to Slash Moderna Vaccine Purchase, Pfizer Single-Sourcing Plan Nixed
  July 28, 2023

• REGULATORY Chuikyo Wary of Abolishing Spillover Rule, Positive on Reviewing Market Expansion Re-Pricing
  July 27, 2023

• REGULATORY Chuikyo Divided Over Raising Premium Rates for Listed Products, Extending Evaluation Data
  July 27, 2023

• BUSINESS After CAR-T Transfer, Gilead Sets Cell Therapy as Key Biz Pillar for Growth in Japan
  July 26, 2023

• REGULATORY MHLW Pharma Bureau Chief Eager to Do Everything on Regulation Panel’s Agenda
  July 25, 2023

• REGULATORY Panel on Generic Industry to Boot Up July 31, Report Expected by Fall
  July 25, 2023

• BUSINESS 7 Drugs Hit 100 Billion Yen Mark in FY2022 Japan Sales, Largest Number in 17 Years
  July 24, 2023

• BUSINESS Sosei to Acquire Idorsia’s Japan and Korea Arms for 65 Billion Yen
  July 21, 2023

• ORGANIZATION JPMA Says IRA Is “Alarming,” Set to Exchange Views with PhRMA
  July 21, 2023

• ORGANIZATION Pseudonymised Data Should Fuel Orphan Drug Discovery, but Criteria and Overseas Usage Must Be Discussed: JPMA
  July 21, 2023

• BUSINESS Heavy Demand Triggers Shipment Curb for High-Dose Mounjaro Just 1 Month after Launch
  July 20, 2023

• BUSINESS Astellas Becomes 1st Japan Pharma to Sue US Govt over IRA
  July 19, 2023

• REGULATORY Japan’s 1st Stelara, G-Lasta Biosimilars Nearing Finish Line
  July 18, 2023

• BUSINESS Gilead Japan Building Sales Force to Prep for Full Oncology Entry: Chief
  July 14, 2023

• REGULATORY Chuikyo Split over Drug Lags and Losses, Rapid Introduction Evaluation System
  July 13, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 50
• 51
• 52
• 53
• 54
• 55
• 56
• 57
• 58
• …
• Next ›
• 最終 »